Singapore markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.4670-0.0438 (-8.57%)
At close: 04:00PM EST
0.4700 +0.00 (+0.64%)
After hours: 07:33PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 93.67M
Enterprise value 12.71M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)55.15
Price/book (mrq)1.21
Enterprise value/revenue 8.26
Enterprise value/EBITDA -0.20

Trading information

Stock price history

Beta (5Y monthly) 1.72
52-week change 3-76.88%
S&P500 52-week change 314.07%
52-week high 34.0000
52-week low 30.4670
50-day moving average 30.7338
200-day moving average 31.2828

Share statistics

Avg vol (3-month) 31.08M
Avg vol (10-day) 3705.74k
Shares outstanding 5125.23M
Implied shares outstanding 6N/A
Float 8124.71M
% held by insiders 10.42%
% held by institutions 139.24%
Shares short (30 Dec 2021) 45.73M
Short ratio (30 Dec 2021) 45.1
Short % of float (30 Dec 2021) 44.60%
Short % of shares outstanding (30 Dec 2021) 44.57%
Shares short (prior month 29 Nov 2021) 46.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,338.11%

Management effectiveness

Return on assets (ttm)-38.76%
Return on equity (ttm)-82.34%

Income statement

Revenue (ttm)1.54M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-92.10%
Gross profit (ttm)-94.33M
EBITDA -65.73M
Net income avi to common (ttm)-43.99M
Diluted EPS (ttm)-0.3870
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)106.86M
Total cash per share (mrq)0.85
Total debt (mrq)25.9M
Total debt/equity (mrq)33.37
Current ratio (mrq)6.51
Book value per share (mrq)0.62

Cash flow statement

Operating cash flow (ttm)-56.71M
Levered free cash flow (ttm)-56.67M